Survey results show Generation Z and millennials have the greatest misunderstandings about sun exposure

Several patients with baseline atopic dermatitis reported symptoms differing from their usual symptoms

Vast majority of patients satisfied with six-month retreatment for glabellar lines utilizing AbobotulinumtoxinA

Among patients with plaque phenotype, high disease activity, and scalp lesions, 52 percent developed severe disease

Increased health care utilization seen for pediatric and adult patients

In second study, bimekizumab showed noninferiority and superiority to adalimumab for moderate-to-severe disease

New diagnosis of psoriasis increases with age, is similar between sexes, and is greatest among Whites

Composite PNI score, calculated from five histopathologic features, is strongest predictor of adverse outcome

Individuals with safety concerns relating to long-term use and in practice for more than 10 years less likely to recommend

Cutaneous immune-related adverse events seen in 25 percent of cancer patients initiating ICI therapy with median onset time of 113 days

About 43 percent of patients who receive anti-PD1 therapy for advanced melanoma have chronic immune-related adverse effects

Findings independent of socioeconomic characteristics, onset age, and other related disorders

Findings show no change in drug retention or effectiveness from before to after the switch

National survey of dermatologists shows that majority believes panel has clinical, patient benefits

Most common were delayed large local reactions, followed by local injection site reactions, urticarial eruptions, morbilliform eruptions

By Physician’s Briefing Staff

Ban could reduce the number of melanoma cases and decrease lifetime health care costs, despite compliance costs

Increased exposure linked to significantly increased rates of incident keratinocyte carcinoma, melanoma in adults ≥66 years

Reduced thickness of melanoma lesions seen for patients receiving routine skin cancer screening, education about self-exam

If 2020 rates continue, burden estimated to increase by about 50 percent for incidence, 68 percent for deaths by 2040

Older age is strong risk factor for cutaneous squamous cell carcinoma, independent of actinic keratosis diagnosis

Nonmodifiable risk factors include gestational diabetes, maternal history of allergy, prenatal history of eczema

Among patients with plaque phenotype, high disease activity, and scalp lesions, 52 percent developed severe disease